How much funding has Parcel Biosciences raised?

Parcel Biosciences has raised $13.5M in total funding, most recently a seed round.

Who are Parcel Biosciences's investors?

Parcel Biosciences's investors include Y Combinator, Breyer Capital, General Catalyst, Metaplanet, SurgePoint Capital, ZAKA VC.

When was Parcel Biosciences founded?

Parcel Biosciences was founded in 2023.

Where is Parcel Biosciences headquartered?

Parcel Biosciences is headquartered in San Francisco, California, United States.

What industry is Parcel Biosciences in?

Parcel Biosciences operates in Biotech, Drug Discovery, Healthcare, Therapeutics.

How many employees does Parcel Biosciences have?

Parcel Biosciences has 1-10 employees.

Parcel Biosciences

Elevated mRNA for transformative medicines.

San Francisco, United States · Founded 2023 · $13.5M raised

YC W24

Headquarters: San Francisco, California
Employees: 1–10
Founded: 2023
Business Model: B2B

Total Funding: $13.5M
Last Round: $13.0M SeedMay 2026
Rounds: 2

About

ParcelBio is a San Francisco-based biotech startup founded in 2023 by former Orbital Therapeutics scientists, developing a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform engineers mRNA to drive significantly higher and more sustained protein expression across diverse cell types, enabling therapeutic applications in autoimmune disease (in vivo CAR-T for pathogenic B cell depletion), oncology, and therapeutic protein delivery. Backed by Breyer Capital, General Catalyst, Y Combinator, and other life science investors.

Summary

Parcel Biosciences is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $13.5M in total across 2 rounds, most recently a $13.0M Seed round in May 2026. Investors include Y Combinator, Breyer Capital and General Catalyst.